Hillsdale Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Buy |
+120
| New | +$18.2K | ﹤0.01% | 500 |
|
|
2021
Q1 | – | Sell |
-35
| Closed | -$9K | – | 563 |
|
|
2020
Q4 | $9K | Buy |
+35
| New | +$9K | ﹤0.01% | 500 |
|
|
2017
Q1 | – | Sell |
-3,900
| Closed | -$297K | – | 482 |
|
|
2016
Q4 | $297K | Hold |
3,900
| – | – | 0.06% | 235 |
|
|
2016
Q3 | $325K | Sell |
3,900
-500
| -11% | -$41.7K | 0.09% | 243 |
|
|
2016
Q2 | $363K | Hold |
4,400
| – | – | 0.11% | 201 |
|
|
2016
Q1 | $334K | Buy |
+4,400
| New | +$334K | 0.11% | 248 |
|
|
2015
Q2 | – | Sell |
-7,100
| Closed | -$563K | – | 516 |
|
|
2015
Q1 | $563K | Sell |
7,100
-90
| -1% | -$7.14K | 0.14% | 119 |
|
|
2014
Q4 | $458K | Hold |
7,190
| – | – | 0.12% | 137 |
|
|
2014
Q3 | $430K | Sell |
7,190
-6,100
| -46% | -$365K | 0.14% | 107 |
|
|
2014
Q2 | $711K | Sell |
13,290
-1,000
| -7% | -$53.5K | 0.16% | 72 |
|
|
2014
Q1 | $862K | Sell |
14,290
-1,410
| -9% | -$85.1K | 0.24% | 50 |
|
|
2013
Q4 | $833K | Buy |
15,700
+5,100
| +48% | +$271K | 0.24% | 56 |
|
|
2013
Q3 | $490K | Hold |
10,600
| – | – | 0.15% | 95 |
|
|
2013
Q2 | $435K | Buy |
+10,600
| New | +$435K | 0.14% | 94 |
|